Postoperative Residual Neuromuscular Paralysis at an Australian Tertiary XXXX 's Hospital.

@entity1 @entity4094 @entity3370 @entity1339 @entity19271
Purpose. @entity4094 ( @entity4094 ) is known to be a significant but frequently overlooked complication after the use of neuromuscular blocking agents (NMBA). Aim of this prospective audit was to investigate the incidence and severity of @entity4094 at our Australian tertiary pediatric center. Methods. All @entity1 receiving NMBA during anesthesia were included over a 5-week period at the end of 2011 (Mondays to Fridays; 8   a.m.-6   p.m.). At the end of surgery, directly prior to tracheal extubation, the @entity3370 ( @entity3370 ) ratio was assessed quantitatively. Data related to @entity1 postoperative outcome was collected in the postoperative acute care unit. Results. Data of 64 @entity1 were analyzed. @entity1339 was given in 34 cases and @entity19271 in 1 @entity1 . The incidence of @entity4094 was 28.1% overall (without reversal: 19.4%; after @entity1339 : 37.5%; n.s.). Severe @entity4094 ( @entity3370 ratio < 0.7) was found in 6.5% after both no reversal and @entity1339 , respectively. Complications in the postoperative acute care unit were infrequent, with no differences between reversal and no reversal groups. Conclusions. In this audit, @entity4094 was frequently observed, particularly in cases where @entity1 were reversed with @entity1339 . These findings underline the well-known problems associated with the use of NMBA that are not fully reversed.
